chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Hypoaesthesia, Musculoskeletal chest pain, Sensory loss
Clinical narrative: a stabbing pain in her ribs; "rubbery" sensation; a numbness on the back of her left thumb; cannot feel pain in it when she pinches it (thumb); headache; The injection site swoll up; injection site swoll up and got red with itching and pain in the area; pain in the area; injection site got red; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (a numbness on the back of her left thumb), SENSORY LOSS (cannot feel pain in it when she pinches it (thumb)), MUSCULOSKELETAL CHEST PAIN (a stabbing pain in her ribs), FEELING ABNORMAL ("rubbery" sensation) and VACCINATION SITE SWELLING (The injection site swoll up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE SWELLING (The injection site swoll up), VACCINATION SITE PRURITUS (injection site swoll up and got red with itching and pain in the area), VACCINATION SITE PAIN (pain in the area) and VACCINATION SITE ERYTHEMA (injection site got red). On 10-Apr-2021, the patient experienced HEADACHE (headache). On 11-Apr-2021, the patient experienced HYPOAESTHESIA (a numbness on the back of her left thumb), SENSORY LOSS (cannot feel pain in it when she pinches it (thumb)) and FEELING ABNORMAL ("rubbery" sensation). On 13-Apr-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (a stabbing pain in her ribs). The patient was treated with IBUPROFEN for Headache, at an unspecified dose and frequency. On 11-Apr-2021, VACCINATION SITE SWELLING (The injection site swoll up), VACCINATION SITE PRURITUS (injection site swoll up and got red with itching and pain in the area) and VACCINATION SITE PAIN (pain in the area) had resolved. On 12-Apr-2021, HEADACHE (headache) had resolved. On 13-Apr-2021, MUSCULOSKELETAL CHEST PAIN (a stabbing pain in her ribs) had resolved. At the time of the report, HYPOAESTHESIA (a numbness on the back of her left thumb), SENSORY LOSS (cannot feel pain in it when she pinches it (thumb)), FEELING ABNORMAL ("rubbery" sensation) and VACCINATION SITE ERYTHEMA (injection site got red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: a stabbing pain in her ribs; "rubbery" sensation; a numbness on the back of her left thumb; cannot feel pain in it when she pinches it (thumb); headache; The injection site swoll up; injection site swoll up and got red with itching and pain in the area; pain in the area; injection site got red; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (a numbness on the back of her left thumb), SENSORY LOSS (cannot feel pain in it when she pinches it (thumb)), MUSCULOSKELETAL CHEST PAIN (a stabbing pain in her ribs), FEELING ABNORMAL ("rubbery" sensation) and VACCINATION SITE SWELLING (The injection site swoll up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE SWELLING (The injection site swoll up), VACCINATION SITE PRURITUS (injection site swoll up and got red with itching and pain in the area), VACCINATION SITE PAIN (pain in the area) and VACCINATION SITE ERYTHEMA (injection site got red). On 10-Apr-2021, the patient experienced HEADACHE (headache). On 11-Apr-2021, the patient experienced HYPOAESTHESIA (a numbness on the back of her left thumb), SENSORY LOSS (cannot feel pain in it when she pinches it (thumb)) and FEELING ABNORMAL ("rubbery" sensation). On 13-Apr-2021, the patient experienced MUSCULOSKELETAL CHEST PAIN (a stabbing pain in her ribs). The patient was treated with IBUPROFEN for Headache, at an unspecified dose and frequency. On 11-Apr-2021, VACCINATION SITE SWELLING (The injection site swoll up), VACCINATION SITE PRURITUS (injection site swoll up and got red with itching and pain in the area) and VACCINATION SITE PAIN (pain in the area) had resolved. On 12-Apr-2021, HEADACHE (headache) had resolved. On 13-Apr-2021, MUSCULOSKELETAL CHEST PAIN (a stabbing pain in her ribs) had resolved. At the time of the report, HYPOAESTHESIA (a numbness on the back of her left thumb), SENSORY LOSS (cannot feel pain in it when she pinches it (thumb)), FEELING ABNORMAL ("rubbery" sensation) and VACCINATION SITE ERYTHEMA (injection site got red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Injection site pain, Lymphadenopathy, Pain
Clinical narrative: Sweating; Pain behind the knees; Pain from Sternum to Pelvis; Pain under the mandible; swelling on the deltoid muscle,under the arm and mandible; Pain on the injection site; cervical lymphadenopathy; Chills; This spontaneous case was reported by a health care professional and describes the occurrence of SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), CHILLS (Chills) and HYPERHIDROSIS (Sweating) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Injury (Cervical injury few years ago on the left side). Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ZINC and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), CHILLS (Chills), PAIN (Pain behind the knees), PAIN (Pain from Sternum to Pelvis) and PAIN (Pain under the mandible). On 02-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Apr-2021, SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), PAIN (Pain behind the knees), PAIN (Pain from Sternum to Pelvis) and PAIN (Pain under the mandible) had resolved. At the time of the report, CHILLS (Chills) and HYPERHIDROSIS (Sweating) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Sweating; Pain behind the knees; Pain from Sternum to Pelvis; Pain under the mandible; swelling on the deltoid muscle,under the arm and mandible; Pain on the injection site; cervical lymphadenopathy; Chills; This spontaneous case was reported by a health care professional and describes the occurrence of SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), CHILLS (Chills) and HYPERHIDROSIS (Sweating) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Injury (Cervical injury few years ago on the left side). Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ZINC and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), CHILLS (Chills), PAIN (Pain behind the knees), PAIN (Pain from Sternum to Pelvis) and PAIN (Pain under the mandible). On 02-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Apr-2021, SWELLING (swelling on the deltoid muscle,under the arm and mandible), INJECTION SITE PAIN (Pain on the injection site), LYMPHADENOPATHY (cervical lymphadenopathy), PAIN (Pain behind the knees), PAIN (Pain from Sternum to Pelvis) and PAIN (Pain under the mandible) had resolved. At the time of the report, CHILLS (Chills) and HYPERHIDROSIS (Sweating) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Her arm became itchy; Red; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Her arm became itchy) and ERYTHEMA (Red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included AMLODIPINE, ATORVASTATIN, LOSARTAN and HYDROCHLOROTHIAZIDE for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced PRURITUS (Her arm became itchy) and ERYTHEMA (Red). At the time of the report, PRURITUS (Her arm became itchy) and ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Erythema, Feeling hot, Myalgia, Swelling
Clinical narrative: sore behind her left ear, it was tender; sore behind her left ear, it was tender; swollen; it was red; it was hot; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (sore behind her left ear, it was tender), TENDERNESS (sore behind her left ear, it was tender), SWELLING (swollen), ERYTHEMA (it was red) and FEELING HOT (it was hot) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESTRADIOL, PROGESTERONE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 10-Mar-2021, the patient experienced MYALGIA (sore arm). On 11-Mar-2021, the patient experienced EAR PAIN (sore behind her left ear, it was tender), TENDERNESS (sore behind her left ear, it was tender), SWELLING (swollen), ERYTHEMA (it was red) and FEELING HOT (it was hot). At the time of the report, EAR PAIN (sore behind her left ear, it was tender), TENDERNESS (sore behind her left ear, it was tender), SWELLING (swollen), ERYTHEMA (it was red), FEELING HOT (it was hot) and MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication reported includes Ibuprofen and ice pack
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: sore behind her left ear, it was tender; sore behind her left ear, it was tender; swollen; it was red; it was hot; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (sore behind her left ear, it was tender), TENDERNESS (sore behind her left ear, it was tender), SWELLING (swollen), ERYTHEMA (it was red) and FEELING HOT (it was hot) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESTRADIOL, PROGESTERONE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 10-Mar-2021, the patient experienced MYALGIA (sore arm). On 11-Mar-2021, the patient experienced EAR PAIN (sore behind her left ear, it was tender), TENDERNESS (sore behind her left ear, it was tender), SWELLING (swollen), ERYTHEMA (it was red) and FEELING HOT (it was hot). At the time of the report, EAR PAIN (sore behind her left ear, it was tender), TENDERNESS (sore behind her left ear, it was tender), SWELLING (swollen), ERYTHEMA (it was red), FEELING HOT (it was hot) and MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication reported includes Ibuprofen and ice pack
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement
Clinical narrative: elevated blood pressure (195/115mmHg); This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (elevated blood pressure (195/115mmHg)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (elevated blood pressure (195/115mmHg)). At the time of the report, BLOOD PRESSURE INCREASED (elevated blood pressure (195/115mmHg)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood pressure measurement: 195/115 High.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       There was no treatment information provided. There were no concomitant medication provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-051434, MOD21-075683 (E2B Linked Report). This case was linked to MOD-2021-077046 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-051434: MOD21-075683:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash erythematous
Clinical narrative: Itching; arm is still very sore; red rash on the arm close to the injection site and it is more on 14Apr2021.; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), RASH ERYTHEMATOUS (red rash on the arm close to the injection site and it is more on 14Apr2021.) and PAIN IN EXTREMITY (arm is still very sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Depression and Allergy. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, BUSPIRONE HYDROCHLORIDE (BUSPAR) for Depression, METOPROLOL for Hypertension.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced RASH ERYTHEMATOUS (red rash on the arm close to the injection site and it is more on 14Apr2021.). On an unknown date, the patient experienced PRURITUS (Itching) and PAIN IN EXTREMITY (arm is still very sore). At the time of the report, PRURITUS (Itching) had resolved and RASH ERYTHEMATOUS (red rash on the arm close to the injection site and it is more on 14Apr2021.) and PAIN IN EXTREMITY (arm is still very sore) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment information was reported.    This case was linked to MOD-2021-105776 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Significant: new event, outcome of event added and second dose details provided
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Vaccination site pain
Clinical narrative: pregnant; Pain at injection site; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) and VACCINATION SITE PAIN (Pain at injection site) in a 44-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage. Concurrent medical conditions included low thyroid.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-Dec-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) and VACCINATION SITE PAIN (Pain at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient is on thyroid medication, a t4 supplement due to low thyroid, over the counter fish oil and over the counter vitamin supplements.   No other medications for treatment are currently being taken.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Internal review conducted on 26jul2021 resulted in updates to pregnancy information
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Mass, Pain in extremity, Pyrexia, Tenderness
Clinical narrative: shortness of breath; a huge mass under his armpit" which "kept getting larger"; pain, tenderness, soreness on his arm, fever, "really bad" shaking; pain, tenderness, soreness on his arm,; "really bad" shaking; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (shortness of breath), MASS (a huge mass under his armpit" which "kept getting larger"), PAIN IN EXTREMITY (pain, tenderness, soreness on his arm, fever, "really bad" shaking), TENDERNESS (pain, tenderness, soreness on his arm,) and TREMOR ("really bad" shaking) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DYSPNOEA (shortness of breath), MASS (a huge mass under his armpit" which "kept getting larger"), PAIN IN EXTREMITY (pain, tenderness, soreness on his arm, fever, "really bad" shaking), TENDERNESS (pain, tenderness, soreness on his arm,), TREMOR ("really bad" shaking) and PYREXIA (fever). In March 2021, MASS (a huge mass under his armpit" which "kept getting larger"), PAIN IN EXTREMITY (pain, tenderness, soreness on his arm, fever, "really bad" shaking), TENDERNESS (pain, tenderness, soreness on his arm,) and PYREXIA (fever) outcome was unknown. At the time of the report, DYSPNOEA (shortness of breath) and TREMOR ("really bad" shaking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes Blood pressure medicine and Heartburn medicine. Treatment medication included Motrin for his symptoms. Patient went to the ER and they did X rays, CT scan, lab work, "and other studies" and in the ER "they didn't know what to say to him". Patient stated that he had again all the symptoms he experienced when he had COVID.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: shortness of breath; a huge mass under his armpit" which "kept getting larger"; pain, tenderness, soreness on his arm, fever, "really bad" shaking; pain, tenderness, soreness on his arm,; "really bad" shaking; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (shortness of breath), MASS (a huge mass under his armpit" which "kept getting larger"), PAIN IN EXTREMITY (pain, tenderness, soreness on his arm, fever, "really bad" shaking), TENDERNESS (pain, tenderness, soreness on his arm,) and TREMOR ("really bad" shaking) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced DYSPNOEA (shortness of breath), MASS (a huge mass under his armpit" which "kept getting larger"), PAIN IN EXTREMITY (pain, tenderness, soreness on his arm, fever, "really bad" shaking), TENDERNESS (pain, tenderness, soreness on his arm,), TREMOR ("really bad" shaking) and PYREXIA (fever). In March 2021, MASS (a huge mass under his armpit" which "kept getting larger"), PAIN IN EXTREMITY (pain, tenderness, soreness on his arm, fever, "really bad" shaking), TENDERNESS (pain, tenderness, soreness on his arm,) and PYREXIA (fever) outcome was unknown. At the time of the report, DYSPNOEA (shortness of breath) and TREMOR ("really bad" shaking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes Blood pressure medicine and Heartburn medicine. Treatment medication included Motrin for his symptoms. Patient went to the ER and they did X rays, CT scan, lab work, "and other studies" and in the ER "they didn't know what to say to him". Patient stated that he had again all the symptoms he experienced when he had COVID.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Epistaxis
Clinical narrative: Sore Right Shoulder; Bloody Nose; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Bloody Nose) and ARTHRALGIA (Sore Right Shoulder) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 045A21A) for an unknown indication.     Previously administered products included for Product used for unknown indication: flu. Past adverse reactions to the above products included Arthralgia with flu. Concurrent medical conditions included Hypertension. Concomitant products included CHONDROITIN SULFATE, GLUCOSAMINE HYDROCHLORIDE (OSTEO BI-FLEX [CHONDROITIN SULFATE;GLUCOSAMINE HYDROCHLORIDE]) from 01-Jan-2019 to an unknown date for Supplementation therapy, CENTRUM MEN from 01-Jan-2002 to an unknown date for Vitamin supplementation.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced EPISTAXIS (Bloody Nose). On 15-Apr-2021, the patient experienced ARTHRALGIA (Sore Right Shoulder). On 14-Apr-2021, EPISTAXIS (Bloody Nose) had resolved. On 18-Apr-2021, ARTHRALGIA (Sore Right Shoulder) had resolved.            No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-May-2021: Follow up received on 22-MAY-2021 Contains Patient demography, Medical history, Concomitant drugs and event outcome were added. On 22-Jul-2021: Follow-up received-ADR form contain no new information
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Skin burning sensation
Clinical narrative: Head to toe rash; Feels like fire under skin; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), RASH (Head to toe rash) and SKIN BURNING SENSATION (Feels like fire under skin) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 06-Apr-2021, the patient experienced RASH (Head to toe rash) and SKIN BURNING SENSATION (Feels like fire under skin). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at an unspecified dose and frequency and TRIAMCINOLONE for Adverse event, at an unspecified dose and frequency. On 01-Apr-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, RASH (Head to toe rash) and SKIN BURNING SENSATION (Feels like fire under skin) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.  No treatment medications were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Lymph node pain, Lymphadenopathy
Clinical narrative: more intense; Left mandibular lymph node under my jaw became very swollen; lymph node hurting; Very tender for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (Very tender for a couple of days), CONDITION AGGRAVATED (more intense), LYMPHADENOPATHY (Left mandibular lymph node under my jaw became very swollen) and LYMPH NODE PAIN (lymph node hurting) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Irritable bowel syndrome and GERD. Concurrent medical conditions included Arthritis. Concomitant products included IBUPROFEN (MOTRIN [IBUPROFEN]), MELOXICAM, OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN C [ASCORBIC ACID], ZINC and VITAMIN D NOS for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CONDITION AGGRAVATED (more intense). In April 2021, the patient experienced LYMPH NODE PAIN (Very tender for a couple of days), LYMPHADENOPATHY (Left mandibular lymph node under my jaw became very swollen) and LYMPH NODE PAIN (lymph node hurting). At the time of the report, LYMPH NODE PAIN (Very tender for a couple of days) was resolving, CONDITION AGGRAVATED (more intense) outcome was unknown and LYMPHADENOPATHY (Left mandibular lymph node under my jaw became very swollen) and LYMPH NODE PAIN (lymph node hurting) had not resolved.            No treatment information was provided.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: delay in second dose. More than 36 after first dose without receiving second dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (delay in second dose. More than 36 after first dose without receiving second dose) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (delay in second dose. More than 36 after first dose without receiving second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (delay in second dose. More than 36 after first dose without receiving second dose) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Vaccination site pain
Clinical narrative: Pain in the arm of the injection; 2nd shot appointment but could not go; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd shot appointment but could not go) and VACCINATION SITE PAIN (Pain in the arm of the injection) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd shot appointment but could not go) and VACCINATION SITE PAIN (Pain in the arm of the injection). At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd shot appointment but could not go) and VACCINATION SITE PAIN (Pain in the arm of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: NNI  No treatment information was reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Headache, Nausea, Pyrexia
Clinical narrative: low back pain; fever; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (low back pain), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No relevant medical history was reported.  Concomitant products included VITAMIN D NOS for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced BACK PAIN (low back pain), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, BACK PAIN (low back pain), PYREXIA (fever), HEADACHE (headache) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: pain in her thighs/pain in her hands; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in her thighs/pain in her hands) and PYREXIA (Fever) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038AZIA) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PYREXIA (Fever). On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in her thighs/pain in her hands). On 16-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in her thighs/pain in her hands) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: (red spot) warm to the touch; red spot little bigger than quarter maybe dollar size; injection site has had a bruise the size of a dime; (bruise) hurting; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (injection site has had a bruise the size of a dime), VACCINATION SITE WARMTH ((red spot) warm to the touch), VACCINATION SITE PAIN ((bruise) hurting) and VACCINATION SITE ERYTHEMA (red spot little bigger than quarter maybe dollar size) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE BRUISING (injection site has had a bruise the size of a dime) and VACCINATION SITE PAIN ((bruise) hurting). On 14-Apr-2021, the patient experienced VACCINATION SITE WARMTH ((red spot) warm to the touch) and VACCINATION SITE ERYTHEMA (red spot little bigger than quarter maybe dollar size). At the time of the report, VACCINATION SITE BRUISING (injection site has had a bruise the size of a dime), VACCINATION SITE WARMTH ((red spot) warm to the touch), VACCINATION SITE PAIN ((bruise) hurting) and VACCINATION SITE ERYTHEMA (red spot little bigger than quarter maybe dollar size) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient denies any itching. No concomitant information was reported. No treatment information was reported.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccinated a 16 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old). On 13-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vaccination site mass, Vaccination site swelling
Clinical narrative: redness below the injection site/redness became the size of baseball; itchiness; swelling; hardness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (hardness), ERYTHEMA (redness below the injection site/redness became the size of baseball), PRURITUS (itchiness) and VACCINATION SITE SWELLING (swelling) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 04BA21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE MASS (hardness) and VACCINATION SITE SWELLING (swelling). On 10-Apr-2021, the patient experienced ERYTHEMA (redness below the injection site/redness became the size of baseball) and PRURITUS (itchiness). At the time of the report, VACCINATION SITE MASS (hardness), ERYTHEMA (redness below the injection site/redness became the size of baseball), PRURITUS (itchiness) and VACCINATION SITE SWELLING (swelling) outcome was unknown.            No concomitant information was reported. No treatment information was reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: fever of 100.9 F; headache; bodyaches; nausea; hardness at injection site; swelling at injection site; approximately a 3 inch circular rash is present at injection site.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.), PYREXIA (fever of 100.9 F) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included QUETIAPINE FUMARATE (SEROQUEL) and CALCIUM for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.). On 11-Apr-2021, the patient experienced PYREXIA (fever of 100.9 F), HEADACHE (headache), MYALGIA (bodyaches) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 12-Apr-2021, PYREXIA (fever of 100.9 F), HEADACHE (headache), MYALGIA (bodyaches) and NAUSEA (nausea) had resolved. At the time of the report, VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, Body temperature: 100.9 f (High) fever of 100.9 F.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site rash, Vaccination site swelling
Clinical narrative: fever of 100.9 F; headache; bodyaches; nausea; hardness at injection site; swelling at injection site; approximately a 3 inch circular rash is present at injection site.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.), PYREXIA (fever of 100.9 F) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included QUETIAPINE FUMARATE (SEROQUEL) and CALCIUM for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.). On 11-Apr-2021, the patient experienced PYREXIA (fever of 100.9 F), HEADACHE (headache), MYALGIA (bodyaches) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 12-Apr-2021, PYREXIA (fever of 100.9 F), HEADACHE (headache), MYALGIA (bodyaches) and NAUSEA (nausea) had resolved. At the time of the report, VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelling at injection site) and VACCINATION SITE RASH (approximately a 3 inch circular rash is present at injection site.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, Body temperature: 100.9 f (High) fever of 100.9 F.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site pain
Clinical narrative: difficulty sleeping; Pain in the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (difficulty sleeping) and VACCINATION SITE PAIN (Pain in the site of injection) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. C13A21A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced INSOMNIA (difficulty sleeping) and VACCINATION SITE PAIN (Pain in the site of injection). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form. On 23-Mar-2021, INSOMNIA (difficulty sleeping) and VACCINATION SITE PAIN (Pain in the site of injection) had resolved.            No concomitant information was reported. The expiration date of both vaccines was recorded as 01Jan1900.   This case was linked to MODERNATX, INC.-MOD-2021-076259 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-076259:Dose 1
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle soreness) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced MYALGIA (Muscle soreness). At the time of the report, MYALGIA (Muscle soreness) outcome was unknown.            Treatment information was not provided.   This case was linked to MOD-2021-039589 (Patient Link).
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Tenderness
Clinical narrative: Stinging in arm; tenderness to the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Stinging in arm) and TENDERNESS (tenderness to the arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (Stinging in arm) and TENDERNESS (tenderness to the arm). On 19-Mar-2021, PAIN (Stinging in arm) had resolved. On 21-Mar-2021, TENDERNESS (tenderness to the arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. Patient he felt stinging in the arm for 3 days and then tenderness to the arm for 5 days. No treatment information was provided.